About this trial
This prospective observational study aims to evaluate the role of intravoxel incoherent motion (IVIM) imaging and magnetic resonance fingerprinting (MRF) techniques in monitoring salivary gland injury in nasopharyngeal carcinoma (NPC) patients undergoing radiotherapy. The study will recruit patients diagnosed with NPC who are receiving standard radiotherapy, and quantitative imaging data will be collected using IVIM and MRF techniques at multiple time points, including pre-treatment, during radiotherapy, and post-treatment. The primary objective is to analyze changes in salivary gland structure and function and to identify early imaging biomarkers indicative of radiation-induced injury. The findings are expected to provide new insights into the dynamic progression of salivary gland damage, establish predictive models for the risk of xerostomia, and guide the development of personalized therapeutic strategies to mitigate long-term complications.
Eligibility criteria
Qualifiers
Histologically or cytologically confirmed diagnosis of nasopharyngeal carcinoma.
Scheduled to undergo radiotherapy as part of standard treatment.
Aged 18 years or older.
No contraindications to MRI scans (e.g., no implanted metallic devices).
Disqualifiers
Contraindications to MRI, such as metallic implants or claustrophobia.
Severe comorbid conditions, including significant renal or hepatic dysfunction.
Concurrent participation in another interventional clinical trial.
Pregnant or breastfeeding.
Trial design
Treatments tested in this trial
- IVIM Imaging MRF Imaging
Treatment groups
Locations
Sponsors and collaborators
Hainan Medical College
Lead sponsor
Hainan People's Hospital
Sponsor institution